Stock Comparison
ALNY vs REGN
Alnylam Pharmaceuticals Inc and Regeneron Pharmaceuticals Inc side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$38.90B
$66.35B
P/E (TTM)
73.0
15.5
Forward P/E
31.3
14.1
Price/Sales
9.1
4.5
Price/Book
36.2
2.1
EV/EBITDA
42.9
10.5
Dividend Yield
—
0.58%
Profitability
Net Margin
12.60%
29.60%
Operating Margin
23.00%
20.70%
Return on Equity
90.40%
14.50%
Return on Assets
10.10%
6.13%
Growth (YoY)
Revenue Growth
96.40%
19.00%
Earnings Growth
0.00%
-7.20%
Price & Risk
Beta
0.3
0.2
52-Week High
$495.55
$818.90
52-Week Low
$273.11
$516.07
Analyst Target
$436.32
$833.31
Compare ALNY and REGN your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.